EMA advisors at the Committee for Medicinal Products for Human Use (CHMP) recommended Sandoz’s adalimumab Humira biosimilar under three brand names – Halimatoz, Hefiya and Hyrimoz. The firm ...

Most are, however, working to get interchangeable status for their biosimilars, and three of them – Organon/Samsung Bioepis’ Hadlima, Sandoz’ Hyrimoz, and Celltrion’s Yuflyma – already ...

After hours: March 21 at 4:08:01 PM EDT Loading Chart for PSO ...

1 Day PSO 0.43% DJIA 0.08% S&P 500 0.08% Energy 0.11% ...